1. Medtech Insight
  2. >>Geography
  3. >>Asia

Malaysia Consults On Medical Device Risk Classifications

 
• By Ashley Yeo

A 20-day consultation on the risk classification of medical devices intended for the Malaysia market ends on 28 February.

Small Flag of Malaysia Sticked in the Map Background with Selective Focus.

Public comment on a new Malaysian guidance document on medical device risk classification is being sought by the Medical Device Authority (MDA). The authority is inviting feedback by 28 February on the updated guidance, which is intended to help the devices industry and health care professionals to comply with Medical Device Act (Act 737) of 2012.

The 36-page document, MDA/GD/0009, applies to devices (defined in guidance MDA/GD/0006) but not to in vitro...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Asia

More from Geography

European Medtechs Reiterate Opposition To Reciprocal Tariffs On US Imports

 
• By Ashley Yeo

EU countermeasures against US tariffs suggest medtech categories exported to the EU could be targeted for tariffs. MedTech Europe and the German IVDs industry have stressed the negative effects this would have on patient care.

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 
• By Natasha Barrow

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By Elizabeth Orr

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.